STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database
STAT
JANUARY 13, 2025
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5 Pharmaceutical company Regeneron has invested $119.5
Let's personalize your content